» Articles » PMID: 23357683

3q26.33-3q27.2 Microdeletion: a New Microdeletion Syndrome?

Overview
Journal Eur J Med Genet
Publisher Elsevier
Specialty Genetics
Date 2013 Jan 30
PMID 23357683
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

We describe three unrelated patients of European descent carrying an overlapping 3q26.33-3q27.2 microdeletion who share common clinical features: neonatal hypotonia, severe feeding problems, specific facial features, abnormal dentition, recurrent upper airways infections, developmental delay and severe growth impairment. One of the patients carries a smaller deletion and presents a milder phenotype. We propose that 3q26.33-3q27.2 microdeletion may represent a novel condition caused by the haploinsufficiency of dosage sensitive genes, several of which are involved in brain development.

Citing Articles

Genomic Variation Affecting MPV and PLT Count in Association with Development of Ischemic Stroke and Its Subtypes.

Ludhiadch A, Sulena , Singh S, Chakraborty S, Sharma D, Kulharia M Mol Neurobiol. 2023; 60(11):6424-6440.

PMID: 37453995 DOI: 10.1007/s12035-023-03460-2.


Defective binding of ETS1 and STAT4 due to a mutation in the promoter region of as a novel mechanism of congenital amegakaryocytic thrombocytopenia.

Capaci V, Adam E, Bar-Joseph I, Faleschini M, Pecci A, Savoia A Haematologica. 2022; 108(5):1385-1393.

PMID: 36226497 PMC: 10153527. DOI: 10.3324/haematol.2022.281392.


3q27.1 microdeletion causes prenatal and postnatal growth restriction and neurodevelopmental abnormalities.

Barua S, Pereira E, Jobanputra V, Anyane-Yeboa K, Levy B, Liao J Mol Cytogenet. 2022; 15(1):7.

PMID: 35241116 PMC: 8895857. DOI: 10.1186/s13039-022-00587-0.


Infantile presentation of 3q26.33-3q27.2 deletion syndrome.

Robilliard R, Caylan M BMJ Case Rep. 2020; 13(11).

PMID: 33257348 PMC: 7705523. DOI: 10.1136/bcr-2019-233215.


Monoallelic loss-of-function THPO variants cause heritable thrombocytopenia.

Cornish N, Aungraheeta M, Fitzgibbon L, Burley K, Alibhai D, Collins J Blood Adv. 2020; 4(5):920-924.

PMID: 32150607 PMC: 7065488. DOI: 10.1182/bloodadvances.2019001293.